MRK: 默沙东

MRK新闻

• 16:55 Personalis: Tempus Bought The Best Part Of The Story (NASDAQ:PSNL)
• 13:30 Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
• 21:50 Merck (MRK) Declines More Than Market: Some Information for Investors
• 15:30 Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
• 12:30 ImmunityBio: Revisiting My Bearish Call After A 250% Rise (Upgrade) (NASDAQ:IBRX)
• 20:42 Dow Jones Futures: Iran Attack Kills Two U.S. Troops; Google, Tesla, AMD Ahead
• 20:42 Dow Jones Futures: Google, Tesla, AMD Loom After AI Stock Sell-Off
• 19:30 Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions (NYSE:MRK)
• 17:02 Stock Market Losses Led By Nasdaq, AI Stocks; Goldman, GE, Taiwan Semi, IBM In Focus: Weekly Review
• 16:50 Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.
• 16:50 MRK Stock Jumps on FDA Nod for Cholesterol-Lowering Pill
• 14:59 MRNA Advances Cancer Pipeline With New Immunotherapy Study
• 13:41 Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies.
• 20:39 Stocks Settle Lower as Chipmakers and AI Stocks Slump
• 20:34 Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Due
• 16:27 SCHD: Your ETF To Hide From The AI Bottleneck Bust (NYSEARCA:SCHD)
• 15:20 Stocks Mixed as Weakness in Chipmakers Weighs
• 15:12 Merck (MRK) Rises after FDA Clears First Oral PCSK9 Cholesterol Pill - TipRanks.com
• 14:07 Stocks Pressured by a Renewed Selloff in Chipmakers
• 13:12 Merck Snags A First-Of-Its-Kind Approval, And Shares Jump
• 13:38 Can Dow Jones' Merck Nab $25 Billion With Its Smart Bomb For Cancer?
• 12:05 Stock Market Today: Nasdaq, S&P 500 Weaken; PayPal Surges On Potential Deal News (Live Coverage)
• 19:06 SELLAS: Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught Up
• 14:30 Here's How Pfizer's Oncology Growth Story Looks Ahead of Q2 Results